English

Eligibility Criteria

5 forms  
Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Subjects originate as patients that have come for a first time visit a Medical Genetics clinic to investigate their apparent inherited CRCP risk. After patients have completed their first clinical visit, they are approached for possible study participation. Subjects are randomized to either arm and later told of the determination after they complete their scheduled clinical results visit (RRV1-Return of CRCP results from UC or UC + WXS). Approximately one month later, all subjects return to the clinic for the research visit RRV2 where WXS subjects receive incidental findings results from exome sequencing and UC subjects have an extended CRCP risk discussion. During this time period and for approximately 1 year more, subjects complete surveys and questionnaires that address the psychosocial/economic aspects of participation in this study. Some subjects are also asked to participate in "Focus Groups" or "Patient Interviews" that comprises a separate minimal risk IRB review.
Description

Subjects originate as patients that have come for a first time visit a Medical Genetics clinic to investigate their apparent inherited CRCP risk. After patients have completed their first clinical visit, they are approached for possible study participation. Subjects are randomized to either arm and later told of the determination after they complete their scheduled clinical results visit (RRV1-Return of CRCP results from UC or UC + WXS). Approximately one month later, all subjects return to the clinic for the research visit RRV2 where WXS subjects receive incidental findings results from exome sequencing and UC subjects have an extended CRCP risk discussion. During this time period and for approximately 1 year more, subjects complete surveys and questionnaires that address the psychosocial/economic aspects of participation in this study. Some subjects are also asked to participate in "Focus Groups" or "Patient Interviews" that comprises a separate minimal risk IRB review.

Data type

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0030705
UMLS CUI [1,3]
C5204638
UMLS CUI [1,4]
C1552784
UMLS CUI [1,5]
C1173690
UMLS CUI [2,1]
C4287881
UMLS CUI [2,2]
C5418626
UMLS CUI [2,3]
C0681850
UMLS CUI [2,4]
C0034656
UMLS CUI [2,5]
C5400986
UMLS CUI [2,6]
C0008952
UMLS CUI [2,7]
C1446911
UMLS CUI [2,8]
C1173690
UMLS CUI [3,1]
C1442880
UMLS CUI [3,2]
C0035168
UMLS CUI [3,3]
C0545082
UMLS CUI [3,4]
C0743997
UMLS CUI [3,5]
C5575842
UMLS CUI [3,6]
C1853667
UMLS CUI [4,1]
C1948053
UMLS CUI [4,2]
C0681850
UMLS CUI [4,3]
C0034394
UMLS CUI [4,4]
C0243156
UMLS CUI [4,5]
C0013556
UMLS CUI [4,6]
C5418626
UMLS CUI [4,7]
C0016400
UMLS CUI [4,8]
C0683518
UMLS CUI [4,9]
C5669842
Back to the top of the page

Similar models

Eligibility Criteria

5 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Subjects originate as patients that have come for a first time visit a Medical Genetics clinic to investigate their apparent inherited CRCP risk. After patients have completed their first clinical visit, they are approached for possible study participation. Subjects are randomized to either arm and later told of the determination after they complete their scheduled clinical results visit (RRV1-Return of CRCP results from UC or UC + WXS). Approximately one month later, all subjects return to the clinic for the research visit RRV2 where WXS subjects receive incidental findings results from exome sequencing and UC subjects have an extended CRCP risk discussion. During this time period and for approximately 1 year more, subjects complete surveys and questionnaires that address the psychosocial/economic aspects of participation in this study. Some subjects are also asked to participate in "Focus Groups" or "Patient Interviews" that comprises a separate minimal risk IRB review.
Item
Subjects originate as patients that have come for a first time visit a Medical Genetics clinic to investigate their apparent inherited CRCP risk. After patients have completed their first clinical visit, they are approached for possible study participation. Subjects are randomized to either arm and later told of the determination after they complete their scheduled clinical results visit (RRV1-Return of CRCP results from UC or UC + WXS). Approximately one month later, all subjects return to the clinic for the research visit RRV2 where WXS subjects receive incidental findings results from exome sequencing and UC subjects have an extended CRCP risk discussion. During this time period and for approximately 1 year more, subjects complete surveys and questionnaires that address the psychosocial/economic aspects of participation in this study. Some subjects are also asked to participate in "Focus Groups" or "Patient Interviews" that comprises a separate minimal risk IRB review.
boolean
C0681850 (UMLS CUI [1,1])
C0030705 (UMLS CUI [1,2])
C5204638 (UMLS CUI [1,3])
C1552784 (UMLS CUI [1,4])
C1173690 (UMLS CUI [1,5])
C4287881 (UMLS CUI [2,1])
C5418626 (UMLS CUI [2,2])
C0681850 (UMLS CUI [2,3])
C0034656 (UMLS CUI [2,4])
C5400986 (UMLS CUI [2,5])
C0008952 (UMLS CUI [2,6])
C1446911 (UMLS CUI [2,7])
C1173690 (UMLS CUI [2,8])
C1442880 (UMLS CUI [3,1])
C0035168 (UMLS CUI [3,2])
C0545082 (UMLS CUI [3,3])
C0743997 (UMLS CUI [3,4])
C5575842 (UMLS CUI [3,5])
C1853667 (UMLS CUI [3,6])
C1948053 (UMLS CUI [4,1])
C0681850 (UMLS CUI [4,2])
C0034394 (UMLS CUI [4,3])
C0243156 (UMLS CUI [4,4])
C0013556 (UMLS CUI [4,5])
C5418626 (UMLS CUI [4,6])
C0016400 (UMLS CUI [4,7])
C0683518 (UMLS CUI [4,8])
C5669842 (UMLS CUI [4,9])
Back to the top of the page